Sequential and Long-term Therapy for Osteoporosis.
1Founding and Emeritus Director, Oregon Osteoporosis Center, Portland, OR, United States of America. mmcclung.ooc@gmail.com.
Effective osteoporosis management requires lifelong strategies. This review discusses therapeutic transitions and proposes intermittent bisphosphonate therapy for sustained osteoporosis treatment and maintenance.
Area of Science:
- Endocrinology
- Pharmacology
- Geriatrics
Background:
- Osteoporosis necessitates lifelong management involving sequential drug therapies and long-term maintenance.
- Understanding drug effects and limitations is crucial for optimizing osteoporosis treatment.
Purpose of the Study:
- To review critical transitions between osteoporosis therapies.
- To outline a strategy for intermittent bisphosphonate therapy in long-term osteoporosis management.
Main Methods:
- Review of extant evidence.
- Analysis of clinical experience.
- Expert opinion synthesis.
Main Results:
- Long-term effects and limitations of bisphosphonates and denosumab are now apparent.
- Key factors for sequential use of anti-remodeling and osteoanabolic agents identified.
- Strategies for drug transitions (estrogen, bisphosphonates, denosumab, bone-forming agents) discussed.
Conclusions:
- Optimizing therapeutic benefits and minimizing safety issues depend on appropriate initial and subsequent drug selection.
- A long-term maintenance strategy ensures sustained benefits from initial osteoporosis therapies.
- Developing a comprehensive life plan is essential for managing patients with osteoporosis.
More Related Videos
07:12Semiautomated Longitudinal Microcomputed Tomography-based Quantitative Structural Analysis of a Nude Rat Osteoporosis-related Vertebral Fracture Model
Published on: September 28, 2017
03:56Author Spotlight: Exploring the Impact of Lingnan Fire-Needle Therapy in Osteoporosis Intervention
Published on: April 26, 2024
Related Concept Videos
Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Osteoclasts in Bone Remodeling
What is the Skeletal System?
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
